Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Follicular 15Lymphoma 15Multiple Myeloma 14Lymphoma, Mantle-Cell 14Leukemia, Myeloid, Acute 14Leukemia, Lymphocytic, Chronic, B-Cell 14Lymphoma, Non-Hodgkin 13Leukemia 13Hodgkin Disease 13Congenital Abnormalities 13Burkitt Lymphoma 13Lymphoma, Large B-Cell, Diffuse 12Lymphoma, B-Cell, Marginal Zone 12Leukemia, Myeloid, Chronic-Phase 12Lymphoma, Large-Cell, Immunoblastic 11Leukemia, Myeloid, Accelerated Phase 11Myeloproliferative Disorders 10Myelodysplastic Syndromes 10Recurrence 9Primary Myelofibrosis 9Lymphoma, T-Cell, Cutaneous 9Dendritic Cell Sarcoma, Interdigitating 9Blast Crisis 8Sezary Syndrome 7Mycosis Fungoides 7Leukemia, Myelomonocytic, Chronic 7Anemia, Refractory, with Excess of Blasts 7Waldenstrom Macroglobulinemia 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

pembrolizumab 3Ipilimumab 3Educational Status 3Biopsy 3Optical Imaging 2Nivolumab 2Early Intervention, Educational 2Ascorbic Acid 2methyl 5-aminolevulinate 1lavender oil 1four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate) 1fludarabine phosphate 1fludarabine 1aldesleukin 1Zinc 1Water 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tomography, Optical Coherence 1Toll-Like Receptor 1 1Tea 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Semaxinib 1Second Harmonic Generation Microscopy 1Risk Factors 1Resistance Training 1Radiotherapy, Image-Guided 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Skin Neoplasms × fludarabine phosphate × Clear all
NCT01701674 2025-12-19

Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
13 enrolled 10 charts
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡